Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma

Progesterone resistance can significantly restrict the efficacy of conservative treatment for patients with endometrial cancer who wish to preserve their fertility or those who suffer from advanced and recurrent cancer. SREBP1 is known to be involved in the occurrence and progression of endometrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaohong, Zhao, Tianyi, Yan, Hong, Guo, Kui, Liu, Zhiming, Wei, Lina, Lu, Wei, Qiu, Chunping, Jiang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155186/
https://www.ncbi.nlm.nih.gov/pubmed/34039951
http://dx.doi.org/10.1038/s41419-021-03762-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155186/
https://www.ncbi.nlm.nih.gov/pubmed/34039951
http://dx.doi.org/10.1038/s41419-021-03762-0

Ejemplares similares